Identification of novel epigenetic modulators of acquired chemoresistance in colon cancer

被引:0
|
作者
Enreig, E. [1 ]
Mancino, M. [1 ]
Fernandez, P. [1 ]
Casado, F. J. [2 ]
Gascon, P. [1 ]
Carbo, N. [2 ]
Ametller, E. [1 ]
Almendro, V. [3 ]
机构
[1] Hosp Clin Barcelona, Med Oncol, Barcelona, Spain
[2] Univ Barcelona, Biochem & Mol Biol, Barcelona, Spain
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Barcelona, Spain
关键词
D O I
10.1016/S0959-8049(14)50410-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
459
引用
收藏
页码:S111 / S111
页数:1
相关论文
共 50 条
  • [1] Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer
    Ponnusamy, Logeswari
    Mahalingaiah, Prathap Kumar S.
    Chang, Yu-Wei
    Singh, Kamaleshwar P.
    CANCER DRUG RESISTANCE, 2019, 2 (02) : 297 - 312
  • [2] PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer
    Nguyen, Chan D. K.
    Colon-Emeric, Benjamin A.
    Murakami, Shigekazu
    Shujath, Mia N. Y.
    Yi, Chunling
    CELL REPORTS, 2024, 43 (05):
  • [3] A TOX-ic axis of epigenetic stem cell maintenance and chemoresistance in colon cancer
    Hubert, Christopher G.
    Stauffer, Shaun R.
    Lathia, Justin D.
    PLOS BIOLOGY, 2023, 21 (09)
  • [4] Epigenetic modulators of thyroid cancer
    Rodriguez-Rodero, Sandra
    Delgado-Alvarez, Elias
    Diaz-Naya, Lucia
    Martin Nieto, Alicia
    Menendez Torre, Edelmiro
    ENDOCRINOLOGIA DIABETES Y NUTRICION, 2017, 64 (01): : 44 - 56
  • [5] Epigenetic biomarkers of chemoresistance in colorectal cancer
    Moutinho, Catia
    Martinez-Cardus, Anna
    Martinez-Balibrea, Eva
    Abad, Albert
    Esteller, Mane
    CANCER RESEARCH, 2012, 72
  • [6] Obesity, insulin and chemoresistance in colon cancer
    Renehan, Andrew G.
    Dive, Caroline
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2011, 2 (01) : 8 - 10
  • [7] RUNX Proteins as Epigenetic Modulators in Cancer
    Yi, Hongyang
    He, Yuhao
    Zhu, Qionghua
    Fang, Liang
    CELLS, 2022, 11 (22)
  • [8] Epigenetic Modulators as Therapeutic Agents in Cancer
    Patnaik, Eshaan
    Madu, Chikezie
    Lu, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (19)
  • [9] Identification of mechanisms driving acquired chemoresistance in preclinical breast cancer models of taxane resistance
    Taylor, Karen J.
    Lyttle, Nicola
    Lao, Linda
    Gourley, Charlie
    Cameron, David A.
    Bartlett, John M. S.
    Spears, Melanie
    CANCER RESEARCH, 2020, 80 (04)
  • [10] Development and validation of a novel epigenetic signature for predicting prognosis in colon cancer
    Luo, Dakui
    Liu, Qi
    Shan, Zezhi
    Cai, Sanjun
    Li, Qingguo
    Li, Xinxiang
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (11) : 8714 - 8723